Propiedad y actividad de insiders de Instil Bio, Inc. (TIL): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $7.18 |
| Capitalización | $49M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-06-11 | McGaughy R Kent Jr | A-Award | 6,500 | $52K |
| 2026-06-11 | Matcham George | A-Award | 6,500 | $52K |
| 2026-06-11 | Gibson Neil W | A-Award | ||
| 2026-06-11 | Binder Gwendolyn | A-Award | 6,500 | $52K |
| 2025-09-10 | Laumas Sandeep | M-Exempt | 13,000 | $165K |
| 2025-09-10 | Laumas Sandeep | M-Exempt | 13,000 | $165K |
| 2025-09-10 | Laumas Sandeep | M-Exempt | 17,000 | $197K |
| 2025-09-10 | Laumas Sandeep | M-Exempt | 17,000 | $197K |
| 2025-09-10 | Laumas Sandeep | S-Sale | 17,539 | $404K |
| 2025-09-10 | Laumas Sandeep | S-Sale | 12,461 | $298K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $8.9M | $241.7M | $37.6M | $43.7M | $9.2M | $8.8M | $6.6M |
| Inversiones a Corto | 0 | 0 | $416.5M | $217.2M | $141.2M | $104.5M | $69.5M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | $848000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $9.3M | $246.1M | $464.0M | $269.4M | $160.8M | $124.5M | $191.4M |
| Inmovilizado Material | $190000 | $55.3M | $122.0M | $209.3M | $141.1M | $130.3M | $364000 |
| Fondo de Comercio | 0 | $5.7M | $5.7M | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $10.1M | $10.1M | 0 | 0 | 0 | 0 |
| Activos Totales | $9.5M | $319.0M | $610.0M | $482.1M | $325.6M | $263.6M | $203.5M |
| Cuentas por Pagar | $979000 | $3.5M | $5.6M | $2.4M | $1.2M | $659000 | $779000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $1.4M | $13.3M | $41.4M | $32.8M | $10.6M | $7.9M | $4.8M |
| Deuda a Largo | 0 | 0 | 0 | $72.3M | $81.4M | $84.2M | $84.8M |
| Pasivos Totales | $1.4M | $26.6M | $54.8M | $118.5M | $99.8M | $94.1M | $89.7M |
| Reservas | -$7.2M | -$44.9M | -$201.7M | -$424.9M | -$581.0M | -$655.1M | -$726.5M |
| Patrimonio Neto | $8.1M | $292.4M | $555.2M | $363.6M | $225.8M | $169.4M | $113.9M |
| Deuda Total | 0 | 0 | 0 | $79.9M | $86.1M | $86.9M | $85.2M |
| Deuda Neta | -$8.9M | -$241.7M | -$454.1M | -$181.0M | -$64.3M | -$26.4M | $9.0M |
| Capital Circulante | $7.9M | $232.9M | $422.7M | $236.6M | $150.2M | $116.6M | $186.6M |
Salud financiera
| Deuda / Patrimonio | 0.03 |
| Ratio corriente | 21.67 |
Rentabilidad
| Rentabilidad sobre capital | -26.78% |
| Rentabilidad sobre capital invertido | -18.61% |
| Rentabilidad sobre activos | -15.32% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ATOS · IFRX · MGNX · ONCY · PLRX · SRZN · STTK
Explorar sector: Healthcare · Biotechnology
Más secciones de TIL: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones